Research Article: Escalating SARS-CoV-2 specific humoral immune response in rheumatoid arthritis patients and healthy controls
Abstract:
Background: Immunocompromised patients are at particular risk of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) infection and previous findings suggest that the infection or vaccination induced immune response decreases over time. Our main goal was to investigate the SARS-CoV-2-specific immune response in rheumatoid arthritis patients and healthy controls over prolonged time.
No summary available.